LIPOCINE INC (LPCN) Stock Income Statement
NASDAQ:LPCN - Nasdaq - US53630X2036 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.67M | 11.20M | -2.85M | 500.00K | 16.14M | |||
| Operating Expenses | 10.14M | 12.35M | 15.08M | 12.62M | 13.00M | |||
| Research and Development | 5.59M | 7.35M | 10.18M | 8.56M | 7.67M | |||
| Selling, General, and Administrative Expenses | 4.55M | 5.00M | 4.90M | 4.06M | 5.33M | |||
| Operating Income | -6.47M | -1.16M | -17.93M | -12.12M | 3.15M | |||
| Interest Income/Expense | 1.04M | 1.15M | 1.37M | 550.00K | -140.00K | |||
| Other Income/Expense | 57.30K | 17.20K | 212.70K | 570.00K | 360.00K | |||
| Non Recurring Items | N/A | N/A | 0.00 | 250.00K | -4.00M | |||
| Income Before Taxes | -5.37M | 9.00K | -16.35M | -10.76M | -630.00K | |||
| Income Tax | 700.00 | 700.00 | 800.00 | 0.00 | 0.00 | |||
| Net Income | -5.37M | 8.40K | -16.35M | -10.76M | -630.00K | |||
| EBITDA | -6.42M | -1.11M | -17.90M | -12.11M | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.02 | 0.00 | -3.10 | -2.06 | -0.12 | |||
| Non GAAP EPS | 0.53 | 1.54 | -3.05 | -2.21 | 0.05 | |||
| Statistics | ||||||||
| Profit Margin | -146.13% | 0.08% | 573.60% | -2152.00% | -3.90% | |||
| Operating Profit Margin | -176.00% | -10.31% | 628.98% | -2424.00% | 19.52% | |||
All data in USD